Register Now

Overview

MASLD is the dominant chronic liver disease world wide. In this talk Dr. Chopra will address the epidemiology clinical features and ways to address the severity of the liver disease in patients with MASLD. Weight loss remains the cornerstone of treatment and the GLP-1 agonist are clearly a game changer. He will also address the most common causes of elevated liver enzymes.

Click here to answer audience response questions, access downloadable slides, and ask questions to the presenter.

Learning Objectives

  • Understand the epidemiology and clinical features of MASLD
  • Appreciate laboratory tests, FIB-4 score, and the use of the FibroScan in assessing severity of MASLD
  • Discuss treatment options for MASLD and mention the potential use of Vitamin D3 and Coffee consumption in addressing Hepatic Fibrosis in these patients
  • Develop a working knowledge of the most prevalent causes of elevated liver enzymes
  • Appreciate that isolated elevations in ALT and AST can be due to non-hepatic origin